Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.58M | $ 9.69M | $ 7.57M |
| Gross Profit | $ -1.70M | $ 0.00 | $ 1.58M | $ 9.69M | $ 7.57M |
| Operating Income | $ -150.07M | $ -228.37M | $ -184.15M | $ -127.20M | $ -97.53M |
| EBITDA | $ -148.38M | $ -205.16M | $ -158.23M | $ -118.85M | $ -95.73M |
| Net Income | $ -149.34M | $ -210.30M | $ -161.34M | $ -123.32M | $ -97.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 190.94M | $ 355.72M | $ 494.25M | $ 331.19M | $ 200.60M |
| Total Assets | $ 225.23M | $ 396.95M | $ 512.15M | $ 350.61M | $ 221.22M |
| Total Debt | $ 29.11M | $ 60.19M | $ 11.37M | $ 15.81M | $ 7.19M |
| Net Debt | $ -16.34M | $ -11.00M | $ -51.86M | $ -17.87M | $ -44.47M |
| Total Liabilities | $ 44.02M | $ 92.87M | $ 38.58M | $ 37.27M | $ 22.16M |
| Stockholders' Equity | $ 181.21M | $ 304.08M | $ 473.58M | $ 313.34M | $ 199.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -128.71M | $ -159.35M | $ -117.28M | $ -96.39M | $ -77.40M |
| Operating Cash Flow | $ -128.34M | $ -155.50M | $ -116.36M | $ -94.63M | $ -75.44M |
| Investing Cash Flow | $ 134.29M | $ 140.34M | $ -127.01M | $ -150.20M | $ 73.70M |
| Financing Cash Flow | $ -31.70M | $ 23.12M | $ 274.40M | $ 226.85M | $ 2.53M |